NO150206C - Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser

Info

Publication number
NO150206C
NO150206C NO781769A NO781769A NO150206C NO 150206 C NO150206 C NO 150206C NO 781769 A NO781769 A NO 781769A NO 781769 A NO781769 A NO 781769A NO 150206 C NO150206 C NO 150206C
Authority
NO
Norway
Prior art keywords
spiring
preparation
therapeutically active
active high
hydantoin compounds
Prior art date
Application number
NO781769A
Other languages
English (en)
Norwegian (no)
Other versions
NO781769L (no
NO150206B (no
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO781769L publication Critical patent/NO781769L/no
Publication of NO150206B publication Critical patent/NO150206B/no
Publication of NO150206C publication Critical patent/NO150206C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO781769A 1977-05-23 1978-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser NO150206C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/799,586 US4130714A (en) 1977-05-23 1977-05-23 Hydantoin therapeutic agents

Publications (3)

Publication Number Publication Date
NO781769L NO781769L (no) 1978-11-24
NO150206B NO150206B (no) 1984-05-28
NO150206C true NO150206C (no) 1984-09-05

Family

ID=25176274

Family Applications (1)

Application Number Title Priority Date Filing Date
NO781769A NO150206C (no) 1977-05-23 1978-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser

Country Status (37)

Country Link
US (1) US4130714A (hu)
JP (1) JPS6035350B2 (hu)
AR (1) AR219531A1 (hu)
AT (1) AT357170B (hu)
AU (1) AU499518B1 (hu)
BE (1) BE867248A (hu)
CA (1) CA1088073A (hu)
CH (1) CH631455A5 (hu)
CS (1) CS200550B2 (hu)
DD (1) DD137107A5 (hu)
DE (2) DE2821966C2 (hu)
DK (1) DK147941C (hu)
EG (1) EG13691A (hu)
ES (1) ES470070A1 (hu)
FI (1) FI62838C (hu)
FR (1) FR2392024A1 (hu)
GB (1) GB1572688A (hu)
GR (1) GR68694B (hu)
HK (1) HK53981A (hu)
HU (1) HU177718B (hu)
IE (1) IE47273B1 (hu)
IL (1) IL54754A (hu)
IN (1) IN147854B (hu)
IT (1) IT1096306B (hu)
KE (1) KE3168A (hu)
LU (1) LU79685A1 (hu)
MY (1) MY8200156A (hu)
NL (1) NL7804158A (hu)
NO (1) NO150206C (hu)
NZ (1) NZ187334A (hu)
PH (1) PH13828A (hu)
PL (1) PL110460B1 (hu)
PT (1) PT68071B (hu)
SE (1) SE437375B (hu)
SU (1) SU873885A3 (hu)
YU (1) YU40829B (hu)
ZA (1) ZA782919B (hu)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4419521A (en) * 1981-11-12 1983-12-06 Pfizer Inc. 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
EP0159143B1 (en) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4656169A (en) * 1984-08-14 1987-04-07 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (en) 1985-06-14 1986-12-18 Pfizer Inc. Intermediate in the production of an asymmetric hydantoin
JPS627654U (hu) * 1985-06-26 1987-01-17
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
AU598366B2 (en) * 1987-03-20 1990-06-21 Alcon Laboratories, Inc. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
EP0536119A4 (en) * 1989-02-10 1993-08-04 Washington Research Foundation Immunoregulatory agents
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) * 1990-06-11 1993-08-17 Pfizer Inc. 1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
AU683620B2 (en) * 1992-09-28 1997-11-20 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
US5521208A (en) * 1993-07-29 1996-05-28 Alcon Laboratories, Inc. Compositions and methods for the treatment of the metabolically impaired and for improved compliance
WO1998046243A2 (en) * 1997-04-15 1998-10-22 Csir Pharmaceutical compositions having appetite suppressant activity
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
EP1337272A2 (en) 2000-11-30 2003-08-27 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
ES2371393T3 (es) 2007-03-12 2011-12-30 Zadec Aps Extracto antidiabético de rooibos.
EP2848252A3 (en) 2007-03-23 2015-06-17 The Board of Regents of the University of Texas System Aldose reductase inhibitors for use in treating uveitis
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
CA2822672C (en) 2010-12-23 2018-06-05 The Board Of Regents Of The University Of Texas System Methods for treating copd
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
GR68694B (hu) 1982-02-01
LU79685A1 (fr) 1979-12-06
DD137107A5 (de) 1979-08-15
SU873885A3 (ru) 1981-10-15
NO781769L (no) 1978-11-24
BE867248A (fr) 1978-11-20
HU177718B (en) 1981-12-28
IT7823672A0 (it) 1978-05-22
US4130714A (en) 1978-12-19
JPS6035350B2 (ja) 1985-08-14
NL7804158A (nl) 1978-11-27
DK147941B (da) 1985-01-14
EG13691A (en) 1982-12-31
DE2821966A1 (de) 1978-11-30
YU116978A (en) 1983-02-28
AR219531A1 (es) 1980-08-29
IT1096306B (it) 1985-08-26
YU40829B (en) 1986-06-30
HK53981A (en) 1981-11-13
CS200550B2 (en) 1980-09-15
AU499518B1 (en) 1979-04-26
ATA365378A (de) 1979-11-15
PT68071A (en) 1978-06-01
PH13828A (en) 1980-10-07
FI781613A (fi) 1978-11-24
PL110460B1 (en) 1980-07-31
IE781015L (en) 1978-11-23
SE7803626L (sv) 1978-11-24
IN147854B (hu) 1980-07-19
FR2392024B1 (hu) 1981-07-24
DK147941C (da) 1985-08-26
IL54754A0 (en) 1978-07-31
SE437375B (sv) 1985-02-25
PT68071B (en) 1979-10-26
CH631455A5 (fr) 1982-08-13
FI62838B (fi) 1982-11-30
FI62838C (fi) 1983-03-10
AT357170B (de) 1980-06-25
MY8200156A (en) 1982-12-31
DE2858042C2 (de) 1983-11-24
PL206826A1 (pl) 1979-04-23
ZA782919B (en) 1979-06-27
CA1088073A (en) 1980-10-21
NZ187334A (en) 1984-04-27
KE3168A (en) 1981-11-06
IE47273B1 (en) 1984-02-08
IL54754A (en) 1982-04-30
DE2821966C2 (de) 1983-06-01
JPS53144575A (en) 1978-12-15
NO150206B (no) 1984-05-28
FR2392024A1 (fr) 1978-12-22
DK226778A (da) 1978-11-24
GB1572688A (en) 1980-07-30
ES470070A1 (es) 1979-01-01

Similar Documents

Publication Publication Date Title
NO150206C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hoeyredreiende spiro-hydantoinforbindelser
NO151240C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
NO150800C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO147950C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO151461C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater
NO810762L (no) Fremgangsmaate for fremstilling av farmakologisk aktive heterocykliske forbindelser
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO781824L (no) Fremgangsmaate ved fremstilling av analgesisk aktive forbindelser
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner